Other Eye Care — Net revenues

Products & Services · Net revenues

AbbVie Other Eye Care — Net revenues increased by 18.5% to $294.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 36.7%, from $215.00M to $294.00M. Over 4 years (FY 2021 to FY 2025), Other Eye Care — Net revenues shows a downward trend with a -3.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2018
Last reportedQ4 2025
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market adoption or successful commercialization of secondary eye care products, while a decrease may signal market saturation, increased competition, or product lifecycle maturity.

Detailed definition

This metric represents the total net revenue generated from the sale of pharmaceutical products within the company's spe...

Peer comparison

Peers in the pharmaceutical industry typically report similar revenue streams under specialized ophthalmology or eye care segments, often categorized by therapeutic area or product franchise.

Metric ID: abbv_segment_other_eye_care_net_revenues

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$301.00M$286.00M$306.00M$278.00M$327.00M$287.00M$283.00M$200.00M$215.00M$207.00M$181.00M$200.00M$225.00M$207.00M$215.00M$217.00M$250.00M$248.00M$294.00M
QoQ Change-5.0%+7.0%-9.2%+17.6%-12.2%-1.4%-29.3%+7.5%-3.7%-12.6%+10.5%+12.5%-8.0%+3.9%+0.9%+15.2%-0.8%+18.5%
YoY Change+8.6%+0.3%-7.5%-28.1%-34.3%-27.9%-36.0%+0.0%+4.7%+0.0%+18.8%+8.5%+11.1%+19.8%+36.7%
Range$181.00M$327.00M
CAGR-0.5%
Avg YoY Growth-1.7%
Median YoY Growth+0.3%

Frequently Asked Questions

What is AbbVie's other eye care — net revenues?
AbbVie (ABBV) reported other eye care — net revenues of $294.00M in Q4 2025.
How has AbbVie's other eye care — net revenues changed year-over-year?
AbbVie's other eye care — net revenues increased by 36.7% year-over-year, from $215.00M to $294.00M.
What is the long-term trend for AbbVie's other eye care — net revenues?
Over 4 years (2021 to 2025), AbbVie's other eye care — net revenues has grown at a -3.6% compound annual growth rate (CAGR), from $1.17B to $1.01B.
What does other eye care — net revenues mean?
The total sales revenue generated from the company's secondary eye care pharmaceutical products.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.